(Q37976485)

26 August 2017

title

Current treatment of severe asthma (English)

1 reference

26 August 2017

0 references

S Hashimoto

1

1 reference

26 August 2017

E H Bel

series ordinal

2

1 reference

26 August 2017

publication date

18 January 2012

1 reference

Clinical & Experimental Allergy

26 August 2017

published in

1 reference

26 August 2017

volume

42

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

693-705

1 reference

Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Systematic assessment of difficult-to-treat asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The Madison Avenue effect: how drug presentation style influences adherence and outcome in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The prevalence of nonadherence in difficult asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Leukotriene antagonists as first-line or add-on asthma-controller therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

A cross-sectional study evaluating the relationship between cortisol suppression and asthma control in patients with difficult asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Compliance, adherence, and concordance: implications for asthma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Occupational asthma in Europe and other industrialised areas: a population-based study. European Community Respiratory Health Survey Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

New insights into occupational asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Long-term outcomes in a prospective cohort of apprentices exposed to high-molecular-weight agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

EAACI position paper: prevention of work-related respiratory allergies among pre-apprentices or apprentices and young workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Investigating severe and fatal asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The link between fungi and severe asthma: a summary of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Specific IgE response to trichophyton and asthma severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Allergen avoidance in the treatment of asthma and rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Allergen avoidance in the treatment of asthma and atopic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Allergen avoidance in the treatment of asthma: problems with the meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Exposure to indoor combustion and adult asthma outcomes: environmental tobacco smoke, gas stoves, and woodsmoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Exposure to traffic: lung function and health status in adults with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Childhood asthma and exposure to traffic and nitrogen dioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Respiratory effects of exposure to diesel traffic in persons with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Effect of nitrogen dioxide and ozone on the risk of dying in patients with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Ozone: a trigger for hospital pediatric asthma emergency room visits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Short-term effects of PM10 and NO2 on respiratory health among children with asthma or asthma-like symptoms: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Detrimental effects of environmental tobacco smoke in relation to asthma severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Impact of smoking on asthma therapy: a critical review of clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Corticosteroid resistance in smokers with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Asthma and cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Effects of smoking cessation on lung function and airway inflammation in smokers with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Reduction in asthma-related emergency department visits after implementation of a smoke-free law.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Smoke-free legislation and hospitalizations for childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Different airway inflammatory responses in asthmatic and healthy humans exposed to diesel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Respiratory effects of relocating to areas of differing air pollution levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Decline of ambient air pollution levels and improved respiratory health in Swiss children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Less air pollution leads to rapid reduction of airway inflammation and improved airway function in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Optimal asthma control, starting with high doses of inhaled budesonide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Significant variability in response to inhaled corticosteroids for persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Safety of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The beta-agonist controversy revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Current issues with beta2-adrenoceptor agonists: historical background.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Regular inhaled beta-agonist treatment in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Asthma control during and after cessation of regular beta 2-agonist treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Beta-adrenoceptor responses of the airways: for better or worse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The "black box" warning and allergy drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Risk of serious asthma exacerbations associated with long-acting beta agonists among patients with asthma: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Serious asthma exacerbations in asthmatics treated with high-dose formoterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Tiotropium bromide step-up therapy for adults with uncontrolled asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Cluster analysis and clinical asthma phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Prognostic factors of asthma severity: a 9-year international prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Association between IgE levels and asthma severity among African American, Mexican, and Puerto Rican patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

21 January 2018

Omalizumab for asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Efficacy and Safety of Subcutaneous Omalizumab vs Placebo as Add-on Therapy to Corticosteroids for Children and Adults With Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Increased sputum and bronchial biopsy IL-13 expression in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Airway fibroblasts in asthma manifest an invasive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Lebrikizumab treatment in adults with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

A comparison of the prevalence of sensitization to antigens among asthmatics in Cleveland and London

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The utility of antifungal agents for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Intolerance to aspirin. Clinical studies and consideration of its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Clinical features and diagnosis of aspirin induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Nitric oxide evaluation in upper and lower respiratory tracts in nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Risk factors of frequent exacerbations in difficult-to-treat asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Unmet needs in severe chronic upper airway disease (SCUAD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Treatment of chronic rhinosinusitis and its effects on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Treatment of aspirin-intolerant asthma with antileukotrienes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Effect of HFA-flunisolide on peripheral lung inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Factors associated with persistent airflow limitation in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

"Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Adverse effects of oral corticosteroids in relation to dose in patients with lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Alternative agents in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Alternate treatments in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Theophylline: new perspectives for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Mepolizumab and exacerbations of refractory eosinophilic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Prospective study of body mass index, weight change, and risk of adult-onset asthma in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

An official American Thoracic Society Workshop report: obesity and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Obesity, waist size and prevalence of current asthma in the California Teachers Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The relationship between obesity and asthma severity and control in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Impact of obesity in asthma: evidence from a large prospective disease management study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Obesity, airway hyperresponsiveness, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Gastroesophageal reflux in patients with morbid obesity: a role of obstructive sleep apnea syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Gastric surgery in morbid obesity. Outcome in patients aged 55 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The effects of bariatric surgery on asthma severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Obstructive sleep apnea syndrome and asthma: the role of continuous positive airway pressure treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Nocturnal asthma: role of snoring and obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Impact of CPAP on asthmatic patients with obstructive sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Efficacy of esomeprazole for treatment of poorly controlled asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Non-eosinophilic asthma: importance and possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Non-eosinophilic cor ticosteroid unresponsive asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

The influence of age on induced sputum differential cell counts in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Qualitative analysis of high-resolution CT scans in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Asthma, atopy and Chlamydia pneumoniae antibodies in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Clarithromycin targets neutrophilic airway inflammation in refractory asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Evidence of a role of tumor necrosis factor alpha in refractory asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Targeting TNF-alpha: a novel therapeutic approach for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Radiofrequency ablation of airway smooth muscle for sustained treatment of asthma: preliminary investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Bronchial thermoplasty for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Asthma control during the year after bronchial thermoplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

High-altitude treatment: a therapeutic option for patients with severe, refractory asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

An integrative systems biology approach to understanding pulmonary diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

High-altitude climate therapy reduces local airway inflammation and modulates lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Patterns of corticosteroid medication use: non-adherence can be effective in milder asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Body mass index and asthma severity in the National Asthma Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

Assessing the Safety of Adding LABAs to Inhaled Corticosteroids for Treating Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03936.X

10.1111/J.1365-2222.2011.03936.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference